← Back to home

Document DOJ-OGR-00026231

AI Analysis

Summary: This medical record documents a medical examination of Jeffrey Epstein on July 12, 2019, noting diagnoses including constipation, hyperlipidemia, low back pain, neuralgia, and sleep apnea, and prescribing medications to treat some of these conditions.
Significance: This document provides insight into Jeffrey Epstein's medical condition and treatment while in custody, potentially relevant to investigations or lawsuits related to his health and death.
Key Topics: Medical examination of Jeffrey Epstein Diagnoses and treatment Medications prescribed
Key People:
  • Jeffrey Epstein - Inmate being examined
  • (b)(6); (b)(7)(C) MD - Medical provider conducting the examination

Full Text

Page 2571 Inmate Name: EPSTEIN, JEFFREY EDWARD Date of Birth: 01/20/1953 Sex: M Race: WHITE Reg #: 76318-054 Encounter Date: 07/12/2019 13:10 Provider: (b)(6): (b)(7)(C) MD Facility: NYM Unit: Z05 Exam: Eyes General Yes: PERRLA, Extraocular Movements Intact Pulmonary Auscultation Yes: Clear to Auscultation Cardiovascular Auscultation Yes: Regular Rate and Rhythm (RRR), Normal S1 and S2 No: M/R/G Abdomen Auscultation Yes: Normo-Active Bowel Sounds Palpation Yes: Within Normal Limits Musculoskeletal Tibia / Fibula No: Edema Back Yes: Tenderness Neurologic Cranial Nerves (CN) Yes: Within Normal Limits Motor System-General Yes: Normal Exam ASSESSMENT: Constipation, unspecified, K5900 - Current Hyperlipidemia, unspecified, E785 - Current Low back pain, M545 - Current Neuralgia and neuritis, unspecified, M792 - Current Sleep apnea, G4730 - Current PLAN: New Medication Orders: Rx# Medication Order Date Prescriber Order Magnesium Hydroxide Susp 07/12/2019 13:10 30 CC Orally - Two Times a Day PRN x 2 day(s) MethylPREDNISolone Tab 4 MG (Dose Pack 21 tab) 07/12/2019 13:10 AS DIRECTED Orally - daily x 6 day(s) Indication: Constipation, unspecified Indication: Neuralgia and neuritis, unspecified Disposition: Generated 07/12/2019 14:20 by (b)(6); (b)(7)(C) MD Bureau of Prisons - NYM Page 2 of 3 DOJ-OGR-00026231 See Amendment